PERSPECTA

News from every angle

Back to headlines

Moderna Develops More Effective mRNA Flu Vaccine

Moderna has developed a new mRNA-based flu vaccine that demonstrated greater protection against illness compared to standard vaccines in a Phase 3 clinical trial.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.